Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

3 May 2022

Policy

Note on Transferable Vouchers – April 2022

22 April 2022

Policy

Advancing Medicines repurposing in the EU

14 March 2022

Policy

Repurposing has emerged as an important strategy to address unmet […]

Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

The Issue of Abuses of Divisional Patent Application

30 April 2021

Policy

EU industrial policy can dramatically improve medicines manufacturing resilience and security of supply

17 March 2021

Policy

Medicines for Europe Position on IP Action Plan – March 2021

13 March 2021

Policy

Maintaining the exchange of critical health data – An adequacy decision on the UK data protection regime

5 March 2021

Policy

Medicines for Europe Position Paper On Patent Linkage

3 March 2021

Policy